首页|ω-3脂肪酸联合辅酶Q10对轻度高脂血症人群血脂干预效果的临床随机对照研究

ω-3脂肪酸联合辅酶Q10对轻度高脂血症人群血脂干预效果的临床随机对照研究

扫码查看
目的:观察ω-3脂肪酸联合辅酶Q10对轻度高脂血症人群血脂、抗氧化及炎症水平的影响。方法:筛选解放军总医院第一医学中心门诊轻度高脂血症患者90例,采用随机、对照前瞻性研究方法,随机分为ω-3脂肪酸联合辅酶Q10组(A组)和对照组(B组),每组45例干预3个月,两组均常规给予低盐低脂饮食和运动指导,A组补充ω-3脂肪酸2粒3次/日和辅酶Q10胶囊2粒2次/日(早、晚)。于干预前、后比较两组间三大营养素摄入量、人体测量指标、体成分变化、血生化、抗氧化及炎症水平的影响。结果:共有82例患者完成研究,A组42例、B组40例。干预前两组间一般情况均无统计学差异(P>0。05);干预前后两组营养素摄入量、人体测量及体成分均无显著性差异(P>0。05);干预结束后两组间肝、肾功能、蛋白水平、胆红素、血脂水平等指标未见显著差异(P>0。05),但比较两组间干预前后差值变化水平(Δ=结束-开始),发现A组ΔTC、ΔLDL-C及△非-HDL-C下降水平显著高于B组(P<0。05);抗氧化水平的影响,发现A组ΔMDA水平显著高于B组(P<0。05),炎症指标水平未见显著性差异(P>0。05)。结论:轻度高脂血症人群补充ω-3脂肪酸和辅酶Q10,对其肝肾功能无不利影响,能改善其血脂及抗氧化水平,起到降低动脉粥样硬化性心血管疾病风险的作用。
Effects of ω-3 Polyunsaturated Fatty Acid Combined with Coenzyme Q10 on Blood Lipid Intervention in Mild Hyperlipidemia:Aclinical Randomized Controlled Study
[Objective]To observe the effects of ω-3 polyunsaturated fatty acid(ω-3PUFA)combined with coenzyme Q10 on the levels of blood lipid,antioxidant and inflammation in mild hyperlipidemia.[Method]A total of 90 patients with mild hyperlipidemia in the First Medical Center of PLA General Hospital were randomly divided into ω-3PUFA combined with coenzyme Q10 group(Group A)and control group(group B)by a randomized,controlled prospective study method.45 patients in each group were treated for 3 months.Both groups were given a low-salt and low-fat diet and exercise guidance.Group A was supplemented with ω-3 PUFA(2 capsules 3 times/day)and coenzyme Q10(2 capsules 2 times/day).The effects of major nutrients intake,anthropometric indices,changes in body composition,blood biochemistry,antioxidant and inflammatory levels were compared between the two groups before and after intervention,respectively.[Result]A total of 82 patients completed the study(group A=42 and group B=40).There was no significant difference between the two groups before intervention(P>0.05).There were no significant differences in nutrient intake,anthropometry and body composition between the two groups before and after intervention(P>0.05).After the intervention,there were no significant differences in liver and kidney function indicators,protein level,bilirubin and lipid level between the two groups(P>0.05),but compared with the difference before and after the intervention(Δ=end-start),it was found that the decrease levels of ΔTC,ΔLDL-C and Δ non-HDL-C in group A were significantly higher than those in group B(P<0.05).The level of ΔMDA in group A was significantly higher than that in group B(P<0.05),and the level of inflammation index was not significantly different(P>0.05).[Conclusion]Supplementation of ω-3 PUFA and coenzyme Q10 in mild hyperlipidemia has no adverse effect on liver and kidney function,can improve lipid and antioxidant levels,and play a role in reducing the risk of atherosclerotic cardiovascular disease.

mild hyperlipidemiaα-linolenic acidω-3 poly unsaturated fatty acidscoenzyme Q10

张新胜、缪婷婷、刘钊、杨荩冉、李丽雅、于志盟、刘英华

展开 >

中国人民解放军总医院第一医学中心营养科,北京 100853

北京中医药大学中药学院,北京 102488

轻度高脂血症 α-亚麻酸 ω-3多不饱和脂肪酸 辅酶Q10

"十三五"国家重点研发计划"食品安全关键技术研发"专项"保健食品风险评估及功能评价"基础研究项目

2018YFC1602100

2024

中国食物与营养
中国农业科学院 国家食物与营养咨询委员会

中国食物与营养

CSTPCD
影响因子:0.754
ISSN:1006-9577
年,卷(期):2024.30(5)